Flagship discovery path · Nature 2026

From 136 datasets
to one checkpoint.

Explore how convergent systems analysis, causal perturbation, molecular mechanism, and functional validation connected KLHL6 to durable CD8 T-cell function.

Begin the path ↓
Interactive case study

The evidence
converges.

Select each stage to follow the logic. This is the lab’s central operating model: map broadly, intersect evidence, resolve mechanism, test phenotype, then engineer.

136 datasets

Map

Build a systems atlas spanning infection, cancer, and engineered T-cell states to identify recurrent programs of dysfunction.

THE SCIENTIFIC CLAIM

Proteostasis can couple exhaustion and mitochondrial fitness.

The published study identifies KLHL6 as an E3-ligase checkpoint connected to TOX and PGAM5 regulation, and tests the mechanism across tumor models and human T cells.

Read the peer-reviewed paper ↗
Publication anchor

The peer-reviewed record.

Each connection is curated to show how published evidence informs the questions, methods, or engineering logic of this research program.

01 · Flagship discovery
Nature

The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction

Open publication
Explore the complete publication archive